MTEM

Molecular Templates, Inc. Common Stock

$8.93 -$0.40 -4.48%



Shares Bought5
Shares Sold5
Total10
Shares Owned0
Last Price$8.93
Total Return$17.42
Range Today$8.77 - $9.35
52 Week Range$3.85 - $11.88
Open$9.35
Market Cap$60.72M
Volume/Average68.56K/91.07K
P/E Ratio-
Dividend/Yield0.00




Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
09-26-17 19:38 10-13-17 14:07 $6.45 $10.00 +$3.55 +55.06% nalyd_97
09-26-17 19:37 10-13-17 14:04 $6.45 $10.04 +$3.59 +55.68% nalyd_97
09-25-17 16:58 10-13-17 14:03 $6.50 $10.10 +$3.60 +55.40% nalyd_97
09-25-17 16:56 10-13-17 14:02 $6.50 $10.00 +$3.50 +53.86% nalyd_97
09-25-17 16:48 10-10-17 19:09 $6.66 $9.83 +$3.17 +47.63% crizisaround nalyd_97